Ares Management Increased Its Holding in Stellus Capital Investment (SCM) as Stock Rose; As Amgen (AMGN) Stock Price Declined, Shareholder Miracle Mile Advisors Lowered by $346,236 Its Holding

December 7, 2017 - By Clifton Ray

Ares Management Llc increased its stake in Stellus Capital Investment Corp (SCM) by 76.96% based on its latest 2017Q2 regulatory filing with the SEC. Ares Management Llc bought 147,406 shares as the company’s stock rose 0.57% with the market. The institutional investor held 338,937 shares of the company at the end of 2017Q2, valued at $4.65M, up from 191,531 at the end of the previous reported quarter. Ares Management Llc who had been investing in Stellus Capital Investment Corp for a number of months, seems to be bullish on the $199.16M market cap company. The stock decreased 0.72% or $0.09 during the last trading session, reaching $12.49. About 98,301 shares traded. Stellus Capital Investment Corporation (NYSE:SCM) has risen 41.16% since December 7, 2016 and is uptrending. It has outperformed by 24.46% the S&P500.

Miracle Mile Advisors Llc decreased its stake in Amgen Inc (AMGN) by 61.62% based on its latest 2017Q2 regulatory filing with the SEC. Miracle Mile Advisors Llc sold 2,013 shares as the company’s stock declined 9.68% while stock markets rallied. The institutional investor held 1,254 shares of the biological products (no diagnostic substances) company at the end of 2017Q2, valued at $216,000, down from 3,267 at the end of the previous reported quarter. Miracle Mile Advisors Llc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $127.92 billion market cap company. The stock decreased 1.37% or $2.45 during the last trading session, reaching $176.22. About 2.52 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since December 7, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.




Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on February, 1. They expect $3.02 earnings per share, up 4.50% or $0.13 from last year’s $2.89 per share. AMGN’s profit will be $2.19B for 14.59 P/E if the $3.02 EPS becomes a reality. After $3.27 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -7.65% negative EPS growth.

Miracle Mile Advisors Llc, which manages about $371.73M and $539.07M US Long portfolio, upped its stake in Vanguard Index Fds (VTV) by 4,645 shares to 19,644 shares, valued at $1.90 million in 2017Q2, according to the filing.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Streetinsider.com which released: “Xencor (XNCR) Secures Milestone Payment from Amgen Inc. (AMGN)” on December 05, 2017, also Marketwatch.com with their article: “Republican tax bill makes big winners of Amgen, Gilead and other drugmakers” published on December 05, 2017, Reuters.com published: “FDA approves heart protection claims for Amgen cholesterol drug” on December 01, 2017. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017” published on November 15, 2017 as well as Investorplace.com‘s news article titled: “3 Big Stock Charts for Monday: Analog Devices, Inc., Amgen, Inc. and Symantec …” with publication date: November 27, 2017.

Investors sentiment decreased to 1.15 in 2017 Q2. Its down 0.10, from 1.25 in 2017Q1. It fall, as 72 investors sold AMGN shares while 463 reduced holdings. 100 funds opened positions while 517 raised stakes. 557.32 million shares or 1.16% less from 563.88 million shares in 2017Q1 were reported. The Alabama-based Mitchell Mcleod Pugh And Williams Inc has invested 0.67% in Amgen Inc. (NASDAQ:AMGN). Beech Hill Advsr has invested 0.19% of its portfolio in Amgen Inc. (NASDAQ:AMGN). California-based Covington Cap Mgmt has invested 0.59% in Amgen Inc. (NASDAQ:AMGN). Paw Cap Corporation invested in 10,000 shares. Vigilant Capital Management Ltd Llc invested in 0.03% or 1,250 shares. 73,864 are owned by Cibc World Markets. Shoker Inv Counsel Inc has 9,943 shares. Highlander Capital Management Limited Liability Com owns 0.3% invested in Amgen Inc. (NASDAQ:AMGN) for 2,200 shares. Tirschwell And Loewy has 2.21% invested in Amgen Inc. (NASDAQ:AMGN). Hilltop accumulated 2,860 shares or 0.14% of the stock. Bank Of Montreal Can has invested 0.45% in Amgen Inc. (NASDAQ:AMGN). Schmidt P J Inv Management accumulated 24,191 shares or 1.27% of the stock. 120,909 were accumulated by Ray Gerald L & Associates. Moreover, Argent has 0.22% invested in Amgen Inc. (NASDAQ:AMGN). Institute For Wealth Mgmt Limited Liability Com stated it has 11,209 shares.

Among 22 analysts covering Amgen Inc. (NASDAQ:AMGN), 10 have Buy rating, 0 Sell and 12 Hold. Therefore 45% are positive. Amgen Inc. had 72 analyst reports since August 3, 2015 according to SRatingsIntel. UBS maintained the stock with “Buy” rating in Thursday, October 29 report. The stock has “Buy” rating by Oppenheimer on Wednesday, July 12. Deutsche Bank maintained Amgen Inc. (NASDAQ:AMGN) on Friday, July 31 with “Buy” rating. BMO Capital Markets maintained the stock with “Buy” rating in Friday, July 21 report. On Wednesday, June 7 the stock rating was maintained by Bernstein with “Hold”. The stock of Amgen Inc. (NASDAQ:AMGN) has “Hold” rating given on Friday, August 26 by Gabelli. The stock has “Buy” rating by Oppenheimer on Monday, June 26. The rating was maintained by Oppenheimer with “Buy” on Friday, July 28. Piper Jaffray maintained Amgen Inc. (NASDAQ:AMGN) rating on Thursday, October 12. Piper Jaffray has “Buy” rating and $193.0 target. The company was maintained on Thursday, October 26 by Morgan Stanley.

More notable recent Stellus Capital Investment Corporation (NYSE:SCM) news were published by: Nasdaq.com which released: “Stellus Capital Investment Corporation (SCM) Ex-Dividend Date Scheduled for …” on November 28, 2017, also Nasdaq.com with their article: “Stellus Capital Investment Corp (SCM) President and CEO Robert T. Ladd Bought …” published on November 17, 2017, Marketwatch.com published: “Stellus Capital Investment Corp.” on August 02, 2011. More interesting news about Stellus Capital Investment Corporation (NYSE:SCM) were released by: Seekingalpha.com and their article: “Stellus Capital Investment’s (SCM) CEO Robert Ladd on Q3 2017 Results …” published on November 10, 2017 as well as Seekingalpha.com‘s news article titled: “Stellus Capital Investment: This 5.75% Baby Bond Started Trading On NYSE” with publication date: August 25, 2017.

Investors sentiment increased to 2.2 in Q2 2017. Its up 1.00, from 1.2 in 2017Q1. It improved, as 4 investors sold SCM shares while 6 reduced holdings. 9 funds opened positions while 13 raised stakes. 3.73 million shares or 34.91% more from 2.76 million shares in 2017Q1 were reported. Next Group invested 0% in Stellus Capital Investment Corporation (NYSE:SCM). Blackrock Inc reported 87,118 shares or 0% of all its holdings. Janney Montgomery Scott Ltd stated it has 16,776 shares or 0% of all its holdings. Ares Mgmt Limited Liability Company holds 338,937 shares or 0.11% of its portfolio. 59,389 were reported by Jpmorgan Chase. Royal Natl Bank Of Canada holds 8,513 shares. 700 were reported by Us Financial Bank De. 81,783 are held by Raymond James & Assoc. Manufacturers Life Insur The reported 0% of its portfolio in Stellus Capital Investment Corporation (NYSE:SCM). Arrowstreet Capital Partnership invested in 11,300 shares. Barclays Public Lc stated it has 0% of its portfolio in Stellus Capital Investment Corporation (NYSE:SCM). Gsa Capital Prtn Llp invested in 0.01% or 10,300 shares. Morgan Stanley reported 82,382 shares stake. Acadian Asset Mngmt Ltd Company has invested 0.01% in Stellus Capital Investment Corporation (NYSE:SCM). Millennium Mngmt Ltd Liability Com holds 171,068 shares or 0% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.